1. Home
  2. FCT vs CCCC Comparison

FCT vs CCCC Comparison

Compare FCT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Senior Floating Rate Income Fund II of Beneficial Interest

FCT

First Trust Senior Floating Rate Income Fund II of Beneficial Interest

HOLD

Current Price

$9.99

Market Cap

261.1M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCT
CCCC
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
261.1M
240.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FCT
CCCC
Price
$9.99
$2.18
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.25
AVG Volume (30 Days)
106.8K
1.7M
Earning Date
01-01-0001
02-26-2026
Dividend Yield
11.29%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$30,108,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.45
$1.09
52 Week High
$10.42
$4.22

Technical Indicators

Market Signals
Indicator
FCT
CCCC
Relative Strength Index (RSI) 55.48 48.53
Support Level $9.93 $1.87
Resistance Level $10.09 $2.33
Average True Range (ATR) 0.06 0.13
MACD -0.02 0.02
Stochastic Oscillator 28.77 65.22

Price Performance

Historical Comparison
FCT
CCCC

About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest

First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: